Immunohistochemical Staining for DNA Mismatch Repair Proteins in Intestinal Tract Carcinoma: How Reliable are Biopsy Samples?

Keywords

Lynch syndrome, MSH6, PMS2, MSH2, Pathology

References

• Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry.Jinru Shia — 2008
• Germline and somatic mutations in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phenotype.Naoki Ohmiya, Sandra S. Matsumoto, Hiroyuki Yamamoto — 2001
• The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch Syndrome: from bench to bedsideC. Richard Boland, Minoru Koi, Dong Kyung Chang — 2007
• Microsatellite instability in colorectal cancerMatej Horvat, Borut Štabuc — 2011
• Regulation of DNA repair in hypoxic cancer cellsRanjit S. Bindra, Meredith E. Crosby, Peter M. Glazer — 2007
• Value of Immunohistochemical Detection of DNA Mismatch Repair Proteins in Predicting Germline Mutation in Hereditary Colorectal NeoplasmsJinru Shia, David S. Klimstra, Khédoudja Nafa — 2005
• Immunohistochemistry as First-line Screening for Detecting Colorectal Cancer Patients at Risk for Hereditary Nonpolyposis Colorectal Cancer Syndrome: A 2-antibody Panel May be as Predictive as a 4-antibody PanelJinru Shia, Laura H. Tang, Efsevia Vakiani — 2009
• Patterns of Morphologic Alteration in Residual Rectal Carcinoma Following Preoperative Chemoradiation and Their Association With Long-term OutcomeJinru Shia, José G. Guillem, Harvey G. Moore — 2004
• Heterogeneous staining for mismatch repair proteins during population-based prescreening for hereditary nonpolyposis colorectal cancer.Natasha Watson, Fabienne Grieu, M. J. Morris — 2007
• Oxidative stress inactivates the human DNA mismatch repair system.Christina L. ␣Chang, Giancarlo Marra, Dharam P. Chauhan — 2002
• Neoadjuvant Therapy Induces Loss of MSH6 Expression in Colorectal CarcinomaFei Bao, Nicole C. Panarelli, Hanna Rennert — 2010
• Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramificationsLynch Ht, P. M. Lynch, S. J. Lanspa — 2009
• Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 stainingElisabeth Mangold, Constanze Pagenstecher, Waltraut Friedl — 2005
• Interobserver variability in the evaluation of mismatch repair protein immunostaining.Louise Laurberg Klarskov, Steen Ladelund, Susanne Holck — 2010
• Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).Heather Hampel, Wendy L. Frankel, Edward W. Martin — 2005
• Semiquantitative assessment of immunohistochemistry for mismatch repair proteins in Lynch syndromeEmma Barrow, Emma Jagger, Judith Brierley — 2010
• Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.Asad Umar, C. Richard Boland, Jonathan P. Terdiman — 2004
• Microsatellite Instability, Immunohistochemistry, and Additional PMS2 Staining in Suspected Hereditary Nonpolyposis Colorectal CancerAndrea E. van der Meulen‐de Jong, Marjo van Puijenbroek, Yvonne Hendriks — 2004
• Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinomaGeoffrey Hall, Adele Clarkson, Amanda Shi — 2010
• Hereditary and Familial Colon CancerKory Jasperson, Thérèse M.F. Tuohy, Deborah W. Neklason — 2010

Cited by

• Lynch or not Lynch? Is that always a question?Chrystelle Colas, Florence Coulet, Magali Svrcek — 2012
• A practical guide to biomarkers for the evaluation of colorectal cancerWei Chen, Wendy L. Frankel — 2019
• The utility of diagnostic biopsy specimens for predictive molecular testing in colorectal cancerWakkas Fadhil, Salih Ibrahem, Rashmi Seth — 2012
• Immunohistochemistry staining for mismatch repair proteins: the endoscopic biopsy material provides useful and coherent results.Alex Vilkin, Yaara Leibovici‐Weissman, Marisa Halpern — 2015
• Managing Young Colorectal Cancer: A UK and Irish PerspectiveSatish K. Warrier, Justin Yeung, A. Craig Lynch — 2014
• Current Lynch Syndrome Tumor Screening Practices: A Survey of Genetic CounselorsStephanie A. Cohen — 2014
• Endoscopic biopsies from gastrointestinal carcinomas and their suitability for molecular analysis: a review of the literature and recommendations for clinical practice and researchMatthew Hale, Takuji Gotoda, Jeremy D. Hayden — 2015
• How reliable is immunohistochemical staining for DNA mismatch repair proteins performed after neoadjuvant chemoradiation?Alex Vilkin, Marisa Halpern, Sara Morgenstern — 2014
• Immunohistochemistry in Gastroenterohepatopancreatobiliary Epithelial Neoplasia: Practical Applications, Pitfalls, and Emerging Markers.Andrew M. Bellizzi — 2013
• Preoperative Diagnosis of Lynch Syndrome With DNA Mismatch Repair Immunohistochemistry on a Diagnostic BiopsySatish K. Warrier, Alison H. Trainer, A. Craig Lynch — 2011
• Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistryJinru Shia, Susanne Holck, Giovanni De Petris — 2013
• Should Microsatellite Instability Be Tested in All Cases of Colorectal Cancer?Guy Rosner, Hana Strul — 2014
• [Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].R. Schneider, Claudia Schneider, Reinhard Büttner — 2014
• Should the grading of colorectal adenocarcinoma include microsatellite instability status?Christophe Rosty, Elizabeth Williamson, Mark Clendenning — 2014
• The Utility of Immunohistochemistry for Providing Genetic Information on TumorsJohn Chan, Yiu-Tung Ip, Wah Cheuk — 2013
• Lynch Syndrome Screening Should Be Considered for All Patients With Newly Diagnosed Endometrial CancerAnne M. Mills, Sofia Liou, James M. Ford — 2014
• Low Mutational Burden of Eight Genes Involved in the MAPK/ERK, PI3K/AKT, and GNAQ/11 Pathways in Female Genital Tract Primary MelanomasKalliopi I. Pappa, G. Vlachos, Maria G. Roubelakis — 2015
• BRAF refines clinical interpretation of mismatch repair deficiency in colorectal cancerLars Henrik Jensen — 2014
• Heterogenous mismatch-repair status in colorectal cancerPatrick Joost, Nynke Veurink, Susanne Holck — 2014
• Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results.Laura Curr Beamer, Marcia L. Grant, Carin R. Espenschied — 2012

Related papers

• A new variant database for mismatch repair genes associated with Lynch syndromeMichael O. Woods, Phillip Williams, Amanda Careen — 2007
• A "two-in-one hit" model of shortcut carcinogenesis in MLH1 Lynch syndrome carriers.Aysel Ahadova, Albrecht Stenzinger, Toni T. Seppälä — 2023
• Protein expression profiles of deoxyribonucleic acid mismatch repair genes: Association with clinicopathological characteristics of Malaysian Lynch syndrome patientsMohd Nizam Zahary, Ravindran Ankathil, Maya Mazuwin Yahaya — 2017
• Mismatch Repair Protein Deficiency is Common in Sebaceous Neoplasms and Suggests the Importance of Screening for Lynch SyndromeElizabeth Plocharczyk, Wendy L. Frankel, Heather Hampel — 2013
• MISMATCH REPAIR GENE VARIATION IN A COHORT OF IRISH LYNCH SYNDROME PATIENTSTimothy J. Ryan, S Foy, J Leyden — 2020
• Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch Syndrome (Hereditary Non-polyposis Colorectal Cancer) casesJames Mueller, Isabella Gazzoli, Prathap Bandipalliam — 2009
• LYNCH SYNDROME VARIANT PATHOGENICITY; THE IMPORTANCE OF REVIEWING RISK CLASSIFICATIONSTimothy J. Ryan, S Foy, J Leyden — 2020